In summary, our data suggest that IRX1 acts as tumor suppressor gene in the pathogenesis of lung adenocarcinoma and epigenetic silencing of IRX1 is associated with advanced stage and impaired prognosis of ADC patients. The gene discussed is IRX1; the disease is neoplasm.